BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12026256)

  • 21. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
    Porcel JM
    Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
    Idell S; Rahman NM
    Ann Am Thorac Soc; 2018 May; 15(5):515-517. PubMed ID: 29361235
    [No Abstract]   [Full Text] [Related]  

  • 23. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; Ozyürek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptokinase for empyema.
    Muers MF
    Lancet; 1997 May; 349(9064):1491-2. PubMed ID: 9167455
    [No Abstract]   [Full Text] [Related]  

  • 25. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
    Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
    Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Western Trauma Association critical decisions in trauma: management of parapneumonic effusion.
    Moore HB; Moore EE; Burlew CC; Moore FA; Coimbra R; Davis JW; Sperry JL; McIntyre RC; Biffl WL
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1372-9. PubMed ID: 22902738
    [No Abstract]   [Full Text] [Related]  

  • 27. Utility of fibrinolytic agents for draining intrapleural infections.
    Bouros D; Schiza S; Siafakas N
    Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter trials of treatment for empyema--after all these years.
    Heffner JE
    N Engl J Med; 2005 Mar; 352(9):926-8. PubMed ID: 15745984
    [No Abstract]   [Full Text] [Related]  

  • 29. [Parapneumonic effusion and empyema].
    Marchi E; Lundgren F; Mussi R
    J Bras Pneumol; 2006; 32 Suppl 4():S190-6. PubMed ID: 17273623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrapleural streptokinase for pleural infection.
    Bouros D; Antoniou KM; Light RW
    BMJ; 2006 Jan; 332(7534):133-4. PubMed ID: 16424471
    [No Abstract]   [Full Text] [Related]  

  • 31. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients.
    Ray TL; Berkenbosch JW; Russo P; Tobias JD
    J Intensive Care Med; 2004; 19(1):44-50. PubMed ID: 15035754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
    Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
    Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug treatment with fibrinolytics (corrected) of secondary empyema secondary to complicated parapneumonic effusion].
    Diéguez EV; Alapont VM; San Román CG; Micó SV; Viguer CG
    Cir Pediatr; 2009 Jul; 22(3):162-7. PubMed ID: 19957867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse alveolar hemorrhages and hemorrhagic pleural effusion after thrombolytic therapy with streptokinase for acute myocardial infarction.
    Ayyub M; Barlas S; Iqbal M; Khurshid SM
    Saudi Med J; 2003 Feb; 24(2):217-20. PubMed ID: 12682693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
    Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parapneumonic Effusion and Empyema.
    Addala DN; Bedawi EO; Rahman NM
    Clin Chest Med; 2021 Dec; 42(4):637-647. PubMed ID: 34774171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The definitions and epidemiology of pleural space infection.
    Strange C; Sahn SA
    Semin Respir Infect; 1999 Mar; 14(1):3-8. PubMed ID: 10197392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
    Tokuda Y; Matsushima D; Stein GH; Miyagi S
    Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VATS: first step in the parapneumonic empyema*.
    Di Napoli G; Ronzini M; Paradies G
    G Chir; 2014; 35(5-6):146-8. PubMed ID: 24979108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of parapneumonic effusions and empyema.
    Sahn SA
    Clin Infect Dis; 2007 Dec; 45(11):1480-6. PubMed ID: 17990232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.